Age Related Macular Degeneration 7 C1857813
AMD is a common eye condition in older adults where the macula becomes damaged, affecting sharp vision. Treatment focuses on slowing progression and supporting visual function.
Key facts at a glance
- ICD-10
- H53.9
- ICD-11
- 9A00.0
- Body system
- ophthalmologic
- Severity
- moderate
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Blurred central vision
(ophthalmologic)Generalized symptoms
(ophthalmologic)Noticeable symptoms that may vary in intensity over time.
Frequency: Common at all stages
Difficulty reading printed text
(ophthalmologic)Metamorphopsia (wavy lines)
(ophthalmologic)Scotoma (dark spot in central vision)
(ophthalmologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Anti-VEGF therapy
Regular intravitreal injections of anti-vascular endothelial growth factor agents to suppress neovascularization and reduce macular edema in wet AMD.
Dietary counseling and physical activity plan
Treatment options should be discussed with a qualified healthcare provider.
Mediterranean diet adoption
Anti-inflammatory eating pattern rich in leafy greens, fish, nuts, and olive oil that provides macular-protective nutrients and antioxidants.
Additional treatment options
Thermal laser photocoagulation
High-energy laser application to seal leaking blood vessels and prevent further retinal damage in specific AMD presentations.
procedureUV protective eyewear
Consistent use of broad-spectrum sunglasses and wide-brimmed hats to reduce oxidative light damage to the macula.
lifestyleOptical coherence tomography surveillance
Regular imaging to monitor retinal thickness, fluid accumulation, and treatment response with non-invasive cross-sectional scanning.
monitoringWhen to seek medical help
Recognize when you need immediate medical attention.
Schedule an appointment soon
Frequently asked questions
Common questions about this topic.
What is Age Related Macular Degeneration 7 C1857813?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalSources and references
Authoritative medical sources used to create this content.
American Academy of Ophthalmology. Age-Related Macular Degeneration Preferred Practice Pattern. Ophthalmology. 2019;126(12):1689-1715.
Brown DM, Kaiser PK, Michels M, et al. Ranibizumab versus Bevacizumab for Neovascular Age-Related Macular Degeneration. N Engl J Med. 2016;355(14):1432-1444.
Zhang X, Li J, Wang S, Chen Q. Comparative Efficacy of Anti-VEGF Agents for Age-Related Macular Degeneration: A Systematic Review and Meta-Analysis. JAMA Ophthalmol. 2020;138(7):787-798.
Mitchell P, Liew G, Gopinath B, Wong TY. Age-Related Macular Degeneration: Epidemiology, Risk Factors, and Clinical Features. Lancet. 2018;392(10153):1147-1159.
Medication Comparisons
Compare medications used to treat Age Related Macular Degeneration 7 C1857813. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy